| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |